|

Gamunex(R) as a Treatment for Neurological Disorder CIDP

- Anonymous
  
  May 10, 2008 at 8:31 am
  
  FDA Grants Priority Review of Talecris Biotherapeutics’s Gamunex(R) as a Treatment for Neurological Disorder CIDP
  5/9/2008
  
  Cut and paste this URL for the story.
  http://www.biospace.com/news_story.aspx?StoryID=95699&full=1

© Copyright GBS|CIDP Foundation International Forums.
Use of this Web site constitutes acceptance of our Terms of Use and Privacy Policy.
GBS|CIDP Foundation International is a 501(c)3 tax-exempt organization.

Translate »

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience. Read more...

Necessary

Always Enabled

Non-necessary

Functional

Performance

Analytics

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

Cookie	Duration	Description
CONSENT	16 years 6 months 14 days 2 hours 6 minutes	No description
cookielawinfo-checkbox-functional	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others	1 year	No description